Best Pharma and Healthcare Mutual Funds 2024 | Top Pharmaceutical Funds in India (2024)

SIP refers to periodic investment in an MF. In this option, you commit to invest a pre-decided amount, at regular intervals, and you get allotted Units based on an MF’s NAV. E.g. Suppose you do an SIP of Rs. 1,000. If, for the 1st month its NAV is Rs. 15, you get 66.67 units. For the 2nd, the NAV is Rs. 25, so you get 40 units. For the 3rd, the NAV is Rs. 20, you get 50 units. At the end of 3 months, you have invested Rs. 3,000 and received 156.67 units at an average NAV of Rs. 19.2.

A Direct Plan means you investing directly thru' an AMC/MF website. As there is no Distributor involved, returns generated by this plan will be higher by the percentage fees paid to a Distributor. We, at MoneyWorks4me, encourage investors to invest in Direct Plans.

Regular Plan is when you invest in an MF scheme through a Distributor or Broker. This means you will end up paying some fees to the Distributor. The fees are directly paid by the AMC to a Distributor. For you as an investor, it is reflected in the lower NAV values, and higher Expense Ratio than a Direct Plan

It is the Fund House or the company responsible for managing investors’ money, and in turn, all the MF schemes.

The money collected by an MF Scheme is invested across asset classes like stocks, debt Funds, gold and cash. The market value of these investments at any given time minus the MF’s liabilities is known as the Fund’s AUM. (E.g. If a Fund’s value of investments is Rs. 100 Cr and liabilities Rs 5 Cr., then AUM is Rs. 95 Cr.) Though, a large AUM denotes a Fund’s popularity and success, it also means restrictions on investing (Fund will have to invest mainly in large companies) and difficulty in replicating past high return performance.

It is the price per unit of the MF scheme. On any given day, NAV is the price at which any investor invests in an MF scheme. NAV = [the market value of all the securities held by the scheme minus its liabilities] ÷ the number of units. Since, market value of securities changes every day, NAV of a scheme also changes every day. Similar to a stock price, a high or low NAV does not affect our investment decision.

A Benchmark is a popular index like the SENSEX, NIFTY or BSE 100, against which a Fund’s performance is gauged. A Fund is supposed to choose a Benchmark based upon the market-section it invests in. E.g. a Mid-Cap Fund may use NSE Midcap Index as its Benchmark. It makes sense to invest in an MF, only if it has consistently beaten its Benchmark performance over a 3-5 year period.

The Expense Ratio is the fee charged by a Mutual Fund for managing its investors’ money. It is shown as a percentage of the Assets Under Management (AUM). E.g. if you invest Rs. 10,000 in a Fund with an Expense Ratio of 1.5%, then you are paying the Fund Rs. 150 to manage your money. As a general rule, you are told to avoid Funds with high Expense Ratio. However, it can also turn to be a good investment, if it consistently generates excess returns (Alpha) over its Expense Ratio.

Load is the fees charged for buying (i.e. Entry load) and selling (i.e. Exit load) MF units. SEBI has scrapped the Entry load wef August 1, 2009. Some Funds may charge Investors an Exit load only on early exit (e.g. within a year of investment) to encourage long-term investment behaviour.

Rolling Returns consider performance on every day or week (or any specified frequency) of a defined period, and hence, tell you how you would have fared regardless of when you chose to invest. E.g. A monthly five-year Rolling Return is return from 1-Jan-2013 to 1-Jan-2018, 1-Feb-2013 to 1Feb-2018, subsequently for all months. For 3-yr or 2-yr rolling, the year changes respectively. We advise our users to look at Rolling Alpha, because it allows you to evaluate the consistency of a Fund’s performance over time - including the ups and downs of market cycles.

Choosing growth option means you will not receive extra units for Dividend declared by the Fund. Instead, the amount will stay invested in the Fund, thereby compounding your returns. Choose this option, if you prefer capital appreciation over regular income from your investment.

An Open-ended Fund or Scheme is one that is available for subscription and re-purchase on a continuous basis. These schemes do not have a fixed maturity period. Investors can conveniently buy and sell units at Net Asset Value (NAV) related prices which are declared on a daily basis. The key feature of open-end schemes is liquidity. The opposite is closed ended where the fund cannot be sold very easily.

Every fund is assessed on the following:

  1. Consistent Outperformers : Track record of having generated returns above a benchmark on a 3-year rolling basis. Consistent performers are Green, followed by Orange. Red have an inconsistent track record on outperforming the index.
  2. The average 3-year rolling returns number appears in the first button.
  3. Quality of Portfolio is assessed based on the quality of each stock held. Predominantly high quality stocks get a Green second button, followed by Orange and Red (large amount of risky stocks).
  4. Upside Potential: Every fund is assessed on what returns it could deliver in the next 5 years based on it.

Select the fund that is Green on Performance which shows it has consistently outperformed the index. Select one with a high average 3-year rolling returns - the number in the first button. And select one with a Green rating on Quality-the second button.

Use the Funds Screener and select the category. It shows the funds with Green on Performance and Quality right on the top. The ones with the higher average 3-year rolling returns are ranked the highest. Funds with less than 5 years returns history are colored Grey on Performance. Since the track record is not for an adequately long period they feature lower in the list.

Build a well-diversified portfolio with funds that assures you of a stable growth through market and economic cycles and funds that enhance your portfolio returns over the long run.

  1. Core Funds: Choose from Large cap, Large and Mid cap and Flexicap funds.
  2. Booster Funds
    1. Choose from Mid and Small cap funds.
    2. Select a Sector or Thematic Fund that is likely to outperform in the long term.

Use the Fund Portfolio Analyzer, Sher-ya-Billi to check if your portfolio will deliver healthy returns or disappoint you. Go to Fund Portfolio Analyzer. You can also upload details of your funds in the Portfolio Manager and see the report on this page.

When adding a new fund check how different is the fund compared to your portfolio by using the link in the Right allocation box on the Fund Decision Maker.

Most investors have more, many more funds that they should-over diversified. This tends to reduce returns. Many investors have more of the same i.e. they have funds that have very similar portfolios and hence the fund portfolio is not well-diversified. Either there are too many large cap dominated funds or far too many mid and small cap funds. What you require is a good, balanced mix. Finally investors don't know when to exit a fund and end up carrying it even though the future upside potential is very low.

Best Pharma and Healthcare Mutual Funds 2024 | Top Pharmaceutical Funds in India (2024)

FAQs

Which pharma fund is best in India? ›

Sectoral-Pharma Funds Returns Calculator
  • Mirae Asset Healthcare Fund.
  • Tata India Pharma & HealthCare Fund.
  • UTI Healthcare Fund.
  • Nippon India Pharma Fund.
  • Aditya Birla Sun Life Pharma & Healthcare Fund.
  • HDFC Pharma And Healthcare Fund.
  • Kotak Healthcare Fund.
  • Quant Healthcare Fund.

Which pharma stock is best in India? ›

Top Pharma Stocks in India in 2024 as per Market Capitalisation
  • Sun Pharmaceutical Industries.
  • Cipla.
  • Dr Reddy's Laboratories.
  • Zydus Lifesciences.
Apr 17, 2024

Is it safe to invest in pharma Mutual Funds? ›

We don't recommend pharma funds to new or inexperienced investors. Investors with a large corpus can use these schemes to diversify their portfolio. However, such investors should invest only 5-10% of their total portfolio in sector schemes like pharma. Well informed investors can also make tactical investments.

How good is Nippon India Pharma Fund? ›

1. Current NAV: The Current Net Asset Value of the Nippon India Pharma Fund as of Apr 19, 2024 is Rs 418.11 for Growth option of its Regular plan. 2. Returns: Its trailing returns over different time periods are: 51.59% (1yr), 17.19% (3yr), 22.73% (5yr) and 20.79% (since launch).

Which pharma mutual fund is best to buy? ›

Best Pharma Sector Mutual Funds to Invest in 2024
Fund Name1Y CAGR 3Y CAGR 5Y CAGR Till Date CAGR
Tata India Pharma & Healthcare Fund (G)15.9%
LIC MF Healthcare Fund (G)10.8%
Aditya Birla Sun Life Pharma & Healthcare Fund (G)14.1%
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund (G)12.1%
6 more rows

Which pharmaceutical funds are best to invest in? ›

5 Best Pharmaceutical ETFs for 2023 Performance
TickerFundYTD Return
PPHVanEck Pharmaceutical ETF5.69%
XPHSPDR S&P Pharmaceuticals ETF0.20%
IHEiShares U.S. Pharmaceuticals ETF-1.44%
FTXHFirst Trust Nasdaq Pharmaceuticals ETF-4.23%
1 more row

What is the best healthcare stock to buy in India? ›

Healthcare Stocks in India (as per market capitalisation)
  • Apollo Hospitals Enterprise.
  • Max Healthcare Institute.
  • Global Health Limited.
  • Fortis Healthcare.
7 days ago

Is Cipla good for long-term investment? ›

Therefore, the pharmaceutical industry should be under your radar if you're aiming to build a strong and diversified portfolio to maximize your return in the stock market. Cipla stock can turn out to be a good investment opportunity in the long run.

Who should not invest in mutual funds? ›

Mutual funds are managed and therefore not ideal for investors who would rather have total control over their holdings. Due to rules and regulations, many funds may generate diluted returns, which could limit potential profits.

Are healthcare funds a good investment? ›

The recent performance surge has lifted the category scorecard of healthcare funds, with an average return of 59% over a one-year period, a compounded annual growth rate (CAGR) of 18% over a three-year period, and 23% CAGR over a five-year period. Consider various sectoral nuances before putting your money in these.

Is it worth investing in pharmaceutical companies? ›

Not only are pharmaceutical stocks excellent defensive investments in an uncertain economy, some pharma stocks pay sizable dividends.

Is Nippon India trustworthy? ›

Nippon India Small Cap Fund is a steady performer. The scheme has been among the toppers in the small cap category in both short and long term. You should ideally sell your equity mutual fund investments at least a couple of years before your financial goal.

Which Nippon India mutual fund is best? ›

List of Nippon India Equity Mutual Funds in India
Fund NameCategoryRating
Nippon India Large Cap FundEquity5
Nippon India Tax Saver (ELSS) FundEquity2
Nippon India ELSS Tax Saver FundEquity2
Nippon India Liquid FundDebt3
7 more rows

Should I invest in Nippon India? ›

You may invest in Nippon India Nifty Small Cap 250 Index Fund via SIP. Nifty Index ETF also works like a small cap ,mid cap and mutual fund . In my opinion you all should invest in this. This is safe and best way for you long turm and short term investment.

Which is the No 1 pharma in India? ›

Sun Pharmaceutical Industries Ltd is the leading pharma company in India by market cap (as of Mar 31, 2023). The company reported revenues of $5,235 million for the fiscal year ended March 2022 (FY2022), an increase of 15.4% over FY2021.

Is it good to invest in PharmaBees? ›

If you are not an expert in the Indian pharma industry, then the PharmaBees ETF is a good way to gain exposure to the sector. The ETF is a low-cost, diversified, and passively managed investment that can help you to achieve your long-term investment goals.

What is the return of Nippon India Pharma Fund? ›

₹6,65,315 20.9% annualised returns.

Top Articles
Latest Posts
Article information

Author: Moshe Kshlerin

Last Updated:

Views: 5965

Rating: 4.7 / 5 (57 voted)

Reviews: 88% of readers found this page helpful

Author information

Name: Moshe Kshlerin

Birthday: 1994-01-25

Address: Suite 609 315 Lupita Unions, Ronnieburgh, MI 62697

Phone: +2424755286529

Job: District Education Designer

Hobby: Yoga, Gunsmithing, Singing, 3D printing, Nordic skating, Soapmaking, Juggling

Introduction: My name is Moshe Kshlerin, I am a gleaming, attractive, outstanding, pleasant, delightful, outstanding, famous person who loves writing and wants to share my knowledge and understanding with you.